- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03354832
In-utero Death and Birth Mortality in Reunion Island (RAMIR)
Research Action on Infant Mortality in Reunion Island Evaluation of Factors Affecting In-utero Foetal Death and New-born Death in Reunion Island
Study Overview
Status
Conditions
Detailed Description
Through the analysis of interview of the mothers that have lost their infant during pregnancy or just after birth, the study aims to draw a picture of the pregnancy cares offer and pregnancy conditions in Reunion Island.
This study is an non interventional case-control study. Socio-economic conditions, pregnancy care and prevention are screened to identified the major cause of foetal or new-born death in Reunion Island. These data are still lacking and will be useful to identify which public health actions that should be organized.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Saint-Pierre, Réunion, 97410
- CHU Reunion Island
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Case: foetal death (foetus weighing more than 500 g or more than 22-amenorrhea weeks old) or new-born death (premature: more than 23-amenorrhea weeks old or mature)
- Control: premature (more than 23-amenorrhea weeks old) or mature new-born, alive when the leave the hospital
Exclusion Criteria:
- medical abortion
- second pregnancy during the study period
- case under forensic expertise
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Foetal death
In-utero dead foetus weighting at least 500 g or 22-amenorrhea weeks old.
In utero death means that death occurs during delivery or per partum
|
A midwife is in charge to interview the mother during the month following the lost of her infant.
|
|
New-born death
New-born dead during post-birth hospital stay and at least 23-amenorrhea weeks old.
|
A midwife is in charge to interview the mother during the month following the lost of her infant.
|
|
Birth control for foetal death
Same gender child born, and alive, in the same hospital, and born on time (37-41 amenorrhea weeks old).
|
A midwife is in charge to interview the mother during her hospital stay
|
|
Birth control for new-born death
Same gender infant born, and alive, in the same hospital, and:
|
A midwife is in charge to interview the mother during her hospital stay
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of suboptimal care
Time Frame: within 4 weeks after birth (control) or lost (case)
|
The main suboptimal care are searched:
|
within 4 weeks after birth (control) or lost (case)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jean-Bernard GOUYON, Pr, Centre Hpospitalier Universitaire de La REUNION
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/CHU/08
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.